Detalles de la búsqueda
1.
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease.
Cell
; 180(1): 79-91.e16, 2020 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31866067
2.
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease.
Cell
; 183(7): 2036-2039, 2020 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33357400
3.
Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies.
Clin Gastroenterol Hepatol
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38723981
4.
Preoperative Risk Factors for Adverse Events in Adults Undergoing Bowel Resection for Inflammatory Bowel Disease: 15-Year Assessment of the American College of Surgeons National Surgical Quality Improvement Program.
Am J Gastroenterol
; 118(12): 2230-2241, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37410929
5.
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.
Am J Gastroenterol
; 118(2): 317-328, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36191274
6.
Single-Cell Transcriptional Survey of Ileal-Anal Pouch Immune Cells From Ulcerative Colitis Patients.
Gastroenterology
; 160(5): 1679-1693, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33359089
7.
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(1): 126-135, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33039584
8.
Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel.
Am J Gastroenterol
; 117(8): 1288-1295, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35416799
9.
An intestinal organoid-based platform that recreates susceptibility to T-cell-mediated tissue injury.
Blood
; 135(26): 2388-2401, 2020 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32232483
10.
P035 Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study.
Am J Gastroenterol
; 116(Suppl 1): S9, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37461954
11.
Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease.
Am J Gastroenterol
; 116(12): 2410-2418, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34797226
12.
Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials.
Dig Dis Sci
; 66(5): 1631-1638, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32445049
13.
Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes.
Dig Dis Sci
; 66(11): 3753-3759, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33474649
14.
Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 18(4): 872-880.e1, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31302306
15.
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 18(13): 2952-2961.e8, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32062041
16.
First-Line Biologics or Small Molecules in Inflammatory Bowel Disease: a Practical Guide for the Clinician.
Curr Gastroenterol Rep
; 22(2): 7, 2020 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32002688
17.
Alvimopan for the Prevention of Postoperative Ileus in Inflammatory Bowel Disease Patients.
Dig Dis Sci
; 65(4): 1164-1171, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31522323
18.
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 17(8): 1533-1540.e2, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30268561
19.
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 17(12): 2497-2505.e1, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30625408
20.
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
Gastroenterology
; 155(3): 687-695.e10, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29857091